你的父母还在乱吃阿司匹林么?( 四 )


[2] 吕相征, 中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南[J]. 中华健康管理学杂志, 2019, 13(1):7.
[3] Colin W. O'Brien, Stephen P. Juraschek, Christina C. Wee. Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey. Annals of Internal Medicine, 2019; DOI: 10.7326/M19-0953.
[4] John J. McNeil, Mark R. Nelson, Robyn L. Woods, et al. Effect of Aspirin on Disability-free Survival in the Healthy Elderly[J]. New England Journal of Medicine, 2018; 379:1519-1528.
[5] John J. McNeil, Rory Wolfe, Robyn L. Woods, et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly [J]. New England Journal of Medicine, 2018; 379:1509-1518.
[6] John J. McNeil, Robyn L. Woods, Mark R. Nelson, et al. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly[J]. New England Journal of Medicine, 2018; 379:1499-1508.
[7] Hong K N, Fuster V, Rosenson R S, et al. How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD[J]. J Am Coll Cardiol. 2017, 24;70(17):2171-2185.
[8] Donna K.Arnett, Roger S.Blumenthal, Michelle A.Albert, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Journal of the American College of Cardiology, 2019, https://doi.org/10.1016/j.jacc.2019.03.010.
[9] Antithrombotic Trialists’ (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials[J]. Lancet 2009; 373: 1849–1860.
[10] Rustam Al-Shahi Salman, MS Dennis, PAG Sandercock, et al. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial[J]. The Lancet, 2019, DOI:https://doi.org/10.1016/S0140-6736(19)30840-2.
[11] ProfRustamAl-Shahi Salman, David PMinks, DipayanMitra, et al. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial[J]. The Lancet Neurology, 2019, 18(7): 643-652.
祝叶华 , 清华大学博士 , 科学撰稿人 , 目前从事科技期刊相关工作 。
本文为严肃科普媒体《返朴》(微信号:fanpu2019)首发 , 《返朴》由国际一流科学家和科普专家担任总编及编委 。 任何媒体转载时须保留《返朴》名称及微信号和作者信息 。 未经许可 , 严禁对包括标题在内的任何改动 。 转载、授权、合作请联系fanpusci@163.com 。

推荐阅读